Legal basis: Article 56 (1) (2) of the Act on public offering – current and periodical information

The Management Board of Creepy Jar S.A. with its registered office in Warsaw (hereinafter referred to as the “Company”) hereby notifies of convening the Ordinary General Meeting of the Company (“OGM”) on 30 May 2023 at 12:00, to be held in the Conference Room of the West Gate building at Al. Jerozolimskie 92, 00-807 Warsaw, with the following agenda:

1. Opening of the OGM;
2. Election of the Chairperson of the OGM;
3. Checking the attendance list, confirming the correctness of convening the OGM and its ability to adopt resolutions;
4. Adoption of the OGM agenda;
5. Adoption of a resolution on the resignation from the appointment of a ballot counting committee;
6. Consideration and approval of the Company's financial statements for the financial year ended 31 December 2022;
7. Adoption of a resolution on the allocation of net profit for the financial year ended on 31 December 2022;
8. Consideration and approval of the Management Board's report on the Company’s activities for the financial year ended on 31 December 2022;
9. Adoption of resolutions on granting discharge to the Members of the Company’s Management Board for the performance of their duties in the financial year ended on 31 December 2022;
10. Adoption of resolutions on granting discharge to the Members of the Company’s Supervisory Board for the performance of their duties in the financial year ended on 31 December 2022;
11. Adoption of a resolution on expressing an opinion on the report of the Company’s Supervisory Board on the remuneration of members of the Management Board and the Supervisory Board;
12. Adoption of a resolution on the establishment of the 2023-2025 Incentive Scheme for key employees and associates and members of the Management Board of Creepy Jar S.A.;
13. Adoption of a resolution on the issue of series A subscription warrants;
14. Adoption of a resolution on the conditional increase in the share capital through the issue of series F shares, depriving the existing shareholders of pre-emptive rights and amendment to the Articles of Association;
15. Adoption of a resolution on the issue of series B subscription warrants;
16. Adoption of a resolution on the conditional increase in the share capital through the issue of series G shares, depriving the existing shareholders of pre-emptive rights and amendment to the Articles of Association;
17. Adoption of a resolution on the introduction of series D, E, F and G shares to trading on the regulated market;
18. Closing of the OGM.

The Company’ Management Board encloses the full content of the notice of the OGM, the content of draft resolutions and documents to be discussed at the OGM, specimens of powers of attorney and specimens of forms to exercise voting rights at the OGM by a proxy (natural persons / legal persons), as well as information on the total number of shares and the number of votes in the Company.